Hillsdale Investment Management Inc. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,514,429
-38.3%
37,237
-26.5%
0.14%
-33.8%
Q1 2023$2,452,856
-34.7%
50,637
-48.5%
0.21%
-33.8%
Q4 2022$3,753,523
-25.5%
98,337
-2.0%
0.32%
-30.3%
Q3 2022$5,037,000
+6357.7%
100,337
+4262.5%
0.46%
+4450.0%
Q2 2018$78,0002,3000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders